Below is a compiled list of scientific research and studies on Cannabidiol (CBD) and it’s potential use for treating Neurodegeneration.
- Molecular Targets of Cannabidiol in Neurological Disorders
- Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
- Cannabidiol: a promising drug for neurodegenerative disorders?
- Transdermal Delivery of Cannabidiol Attenuates Binge Alcohol-Induced Neurodegeneration in a Rodent Model of an Alcohol Use Disorder
- Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets
- Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells
- Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia.
- Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke.
- Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons
- Interactions between cannabidiol and Δ9-THC following acute and repeated dosing: Rebound hyperactivity, sensorimotor gating and epigenetic and neuroadaptive changes in the mesolimbic pathway.
- Neurological Aspects of Medical Use of Cannabidiol